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Abstract
Patients with multimorbidity and complex health care needs are usually vulnerable elders
with several concomitant advanced chronic diseases. Our research aim was to evaluate dif-
ferences in patterns of multimorbidity by gender in this population and their possible prog-
nostic implications, measured as in-hospital mortality, 1-month readmissions, and 1-year
mortality. We focused on a cohort of elderly patients with well-established multimorbidity cri-
teria admitted to a specific unit for chronic complex-care patients. Multimorbidity criteria, the
Charlson, PROFUND and Barthel indexes, and the Pfeiffer test were collected prospectively
during their stays. A total of 843 patients (49.2% men) were included, with a median age of
84 [interquartile range (IQR) 79–89] years. The women were older, with greater functional
dependence [Barthel index: 40 (IQR:10–65) vs. 60 (IQR: 25–90)], showed more cognitive
deterioration [Pfeiffer test: 5 (IQR:1–9) vs. 1 (0–6)], and had worse scores on the PROFUND
index [15 (IQR:9–18) vs. 11.5 (IQR: 6–15)], all p <0.0001, while men had greater comorbid-
ity measured with the Charlson index [5 (IQR: 3–7) vs. 4 (IQR: 3–6); p = 0.002]. In the multi-
morbidity criteria scale, heart failure, autoimmune diseases, dementia, and osteoarticular
diseases were more frequent in women, while ischemic heart disease, chronic respiratory
diseases, and neoplasms predominated in men. In the analysis of grouped patterns, neuro-
logical and osteoarticular diseases were more frequent in females, while respiratory and
cancer predominated in males. We did not find gender differences for in-hospital mortality,
1-month readmissions, or 1-year mortality. In the multivariate analysis age, the Charlson,
Barthel and PROFUND indexes, along with previous admissions, were independent predic-
tors of 1-year mortality, while gender was non-significant. The Charlson and PROFUND
indexes predicted mortality during follow-up more accurately in men than in women (AUC
0.70 vs. 0.57 and 0.74 vs. 0.62, respectively), with both p<0.001. In conclusion, our study
shows differing patterns of multimorbidity by gender, with greater functional impairment in
women and more comorbidity in men, although without differences in the prognosis. More-
over, some of these prognostic indicators had differing accuracy for the genders in predict-
ing mortality.
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Introduction
Globally, from 1990 to 2017, life expectancy increased by 7.4 years, reaching 80 years in some
developed countries [1]. The aging population is linked to a marked growth in the prevalence
of elderly patients with multiple concomitant chronic diseases. Recent studies have shown that
the mean of these chronic diseases is about five in the general population over 80 years of age,
and increasing to eight in hospitalized patients [2,3].
This has led to the search for new concepts and terminologies to replace the classic defini-
tion of comorbidity–understood as a primary disease with other secondary associated condi-
tions–given the difficulty in deciding which disease is the predominant one in an individual
patient. Regarding these newly proposed concepts, several authors have suggested as more
appropriate the term multimorbidity, defined as the presence of two or more concomitant
long-term diseases in the same patient [4,5].
About 7% of the total European population suffers from multimorbidity, and this preva-
lence can reach 90% in people over 85 years of age [6,7]. Consistently across studies, elderly
people and those with lower incomes are more likely to be affected by multimorbidity [7]. In
some investigations, female gender is also related to greater multimorbidity but with a longer
survival, in the so-called "male-female health-survival paradox" [8]. This paradox refers to the
fact that the greater life expectancy in women is penalized by several chronic diseases that
entail an increased burden of disabling physical impairment and functional dependence. Con-
versely, males are more susceptible to chronic disease conditions with a worse vital prognosis,
such as cancer and ischemic heart disease [1].
Multimorbidity is associated with a lower quality of life, poorer prognosis, and an increase
in health expenditure. In addition, a subgroup of those with multimorbidity is acknowledged
to require more complex health care: frail elders with several concomitant chronic diseases,
repeated hospitalizations, and frequent ambulatory health care requirements [5].
To date, multiple studies have investigated the impact, according to gender, of comorbidi-
ties on patients with a single chronic disease [9]. Similarly, several population-based reports
have looked at gender differences in patients with multimorbidity [5,10]. However, the quality
of evidence on gender differences in clinical practice with elderly patients hospitalized with
multimorbidity is poor, and prospective studies evaluating the prognosis of these patients are
lacking [7]. Recently, the guidelines for multimorbidity of the National Institute for Health
and Care Excellence (NICE) highlighted the need for prospective studies in patients with well-
defined multimorbidity criteria in order to evaluate their prognosis [11].
Our main objective was to prospectively analyze the characteristics and differences in gen-
der patterns of multimorbidity in hospitalized elderly patients and the prognostic implications
of these characteristics and differences in terms of readmissions and mortality.
Methods
This was a prospective cohort study, evaluating all patients admitted to a hospital medical
ward specialized in the care of multimorbidity patients in the University Hospital Mutua de
Terrassa, from September 1, 2015, to December 31, 2016. The patients were included on the
basis of the first admission in the unit, excluding subsequent readmissions. Only patients with
two or more of the following criteria were included: age� 75 years, b)� 2 chronic diseases,
defined by a multimorbidity scale or Charlson index, c) Barthel� 75 points, and 4)
Pfeiffer� 3 points [12,13,14,15].
Briefly, the unit is dedicated to the prevention, detection, and treatment of complications of
hospitalization, preserving physical capacity, individualizing the management plan, and coor-
dinating the hospital discharge with outpatient care units [6]. Patient data are shared through
Gender and multimorbidity
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an electronic medical record with the primary care physician and nurses, and those specific
outpatient units specialized in the care of chronic complex patients.
During the stay, medical and social variables were collected alongside those concerning
domiciliary treatment. Multimorbidity was evaluated using the multimorbidity classification
of the Spanish Department of Health that includes 15 chronic pathologies selected for relevant
severity or impact on daily life activities [11]. “S1 Table”. The number of chronic diseases was
also collected with the Charlson index, the ESMI scale for other comorbid conditions not
included in the Charlson index, and the PROFUND index [13,16,17]. “S2 and S3 Tables”.
The PROFUND index is a multicomponent prognostic scale designed and validated for
patients with multimorbidity, which includes variables such as age, presence of the main care-
giver, dyspnea, delirium during admission, physical functional dependence, and the number
of hospitalizations in the previous year. PROFUND scores range from 0 to 36 points [17].
Physical functional status was assessed with the Barthel index, while cognitive status was mea-
sured using the Pfeiffer test and, in some cases—for example, suspicion of dementia previously
undiagnosed—complemented with the Mini-Mental Cognitive Examination in the Spanish
version by Lobo et al. (MMCE) [18]. Delirium was diagnosed using the confusion assessment
method, and dysphagia was evaluated by a speech therapist [19]. Additionally, patients were
grouped into the most clinically relevant patterns of disease: a) metabolic diseases (chronic
kidney disease, diabetes mellitus, hypertension, dyslipidemia, and obesity); b) cardiovascular
diseases (ischemic heart disease, heart failure, arrhythmias, cerebrovascular disease, and
peripheral vascular disease); c) respiratory diseases (chronic obstructive pulmonary disease,
asthma, pulmonary fibrosis, and sleep apnea); d) neurological-psychiatric diseases (neurologi-
cal motor diseases, dementia, depression, and anxiety); e) osteoarticular diseases (osteoarthri-
tis, osteoporosis, and osteoporotic fractures); f) cancer (active neoplasm); and g) miscellanea
(autoimmune disease, bowel disease, hepatopathy, anemia, and thromboembolic disease).
Mortality was evaluated in terms of its occurrence during index admission and at 1-year’s
follow-up, while hospital readmissions were evaluated at 30-days and 1 year after the hospital
discharge. Variables associated with prognosis with respect to in-hospital mortality, readmis-
sions, and mortality during follow-up were explored and their gender differences analyzed.
The follow-up was done through telephone calls, contact with the primary care physician, and
review of electronic medical records.
Statistical analysis
Qualitative variables were expressed as absolute frequencies and percentages, while quantitative
variables were summarized as mean and standard deviation (SD) in the case of normal distribu-
tion, or median and interquartile range. Comparison among means was made with the Student’s
t-test for independent samples and the non-parametric test (Mann-Whitney U) for variables not
distributed normally. Either the x2 test or the Fisher exact test was used for the comparison of pro-
portions. Hazard ratios and 95% confidence intervals for survival time were calculated with Cox
regression models, and statistical significance was obtained with the long-rank test. Multivariate
analysis for mortality was also calculated with Cox logistic regression analysis. Variables entered
in the model were chosen based on univariant analysis results and clinical significance.
For validation purposes, we used the cumulative/dynamic area under the receiver operating
characteristic curve (ROC) to express the ability of different variables to predict all-cause
1-year mortality, both globally and distributed by gender. Dynamic cumulative ROC curves
were selected as they are considered the most appropriate method when the considered out-
come (in our case mortality) is a time-dependent variable [20,21]. We used the nearest-neigh-
bor estimator (NNE) proposed by Heagerty, Lumley, and Pepe to estimate the area under the
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curve (AUC), and the naïve bootstrap procedure to estimate 95% confidence interval (95% CI)
[20]. Detailed methodology is available elsewhere [21].
The STROBE check-list for cross-sectional studies is detailed in a supporting information
file [22]. “S4 Table”. The researchers read out explanations and provided them in written
form, and informed consent was obtained from the patients, or, when this was impossible due
to physical or cognitive impairment, from the caregivers. The signature was always made in
the presence of the researcher and the patient. The Ethics and Clinical Trials Committee of the
University Hospital Mutua de Terrassa approved the study.
Results
Overall, 975 admissions of 885 patients were analyzed. Of these, 42 patients were excluded due
to insufficient multimorbidity criteria. “Fig 1”. The excluded patients were younger, with
lower scores on the comorbidity scale and Pfeiffer and Charlson indexes, and with less func-
tional dependence. No differences were found regarding sex and length of stay. “S5 Table”.
Differences by gender
The 843 patients included (49.2% men) had a median age of 84 (IQR: 79–89) years. As shown
in Table 1, women were older, with greater functional dependence (Barthel index), more cog-
nitive deterioration (Pfeiffer test), and worse scores on the PROFUND index (all p<0.0001).
In contrast, men had greater comorbidity as measured by the Charlson index without age
adjustment (p = 0.002). In the multimorbidity scale, heart failure, autoimmune diseases,
dementia, and osteoarticular diseases were more frequent in women, while ischemic heart dis-
ease, chronic respiratory diseases, and neoplasms predominated in men. “Table 1”.
In the analysis of grouped patterns, neurological and osteoarticular diseases were more fre-
quent in females, while respiratory diseases and cancer predominated in males. “Table 2”.
Similarly, the relation between the different grouped patterns of multimorbidity also dif-
fered by gender. The most frequent association in both genders was between cardiovascular
and metabolic diseases. Cardioneurological pattern was the most frequent in women, while a
cardiorespiratory pattern predominated in men. “Fig 2”. Differences by gender in the diverse
combinations of patterns are detailed in “S6 Table”. “S1 Fig”.
Fig 1. Flowchart of participants.
https://doi.org/10.1371/journal.pone.0227252.g001
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In-hospital mortality
One hundred twenty-two patients (14.9%)—63 (15.2%) males and 59 (13.8%) females—died
during their stay, without significant gender differences. Deceased patients were older [87
(IQR:82–91) vs. 84 (IQR:11.6); p<0.0001] years, with more comorbidity criteria measured
with the Charlson index [5 (IQR:3–7) vs. 4 (IQR:3–6);p = 0.007], more functional dependence
[Barthel 35 (IQR:10–69) vs. 55 (IQR:15–80); p = 0.0001], higher scores on PROFUND index
Table 1. Differences by gender in the studied population.
Quantitative variables Men
(mean ± SD)
Women
(mean ± SD)
Total
(mean ± SD)
Men (median;
IQR)
Women (median;
IQR)
Total (median;
IQR)
p
Age � 80.5 (10.4) 84.2 (8.8) 82.4 (9.8) 83 (75–87) 85.5 (80–89) 84 (79–89) <0.0001
Barthel� 57.9 (34.5) 41.1 (32.2) 49.4 (34.4) 60 (25–90) 40 (10–65) 50 (15–80) <0.0001
Pfeiffer� 3.1 (3.7) 5.3 (6.6) 4.2 (5.5) 1 (0–6) 5.3 (6.6) 2 (0–9) <0.0001
Mini Mental Cognitive
Examination�
25.5 (9.5) 18.3 (11.6) 21.7 (11.2) 25 (20–32) 18.3 (10–30) 21.7 (14.8–32) 0.001
Charlson age-adjusted� 8.7 (2.7) 8.4 (2.3) 8.6 (2.5) 9 (7–10) 8 (7–10) 8 (7–10) 0.1
Charlson � 5.4 (4.3) 4.5 (2.1) 4.9 (3.4) 5 (3–7) 4 (3–6) (2.1) 4 (3–6) 0.002
PROFUND � 11 (6.3) 13.4 (5.9) 12.2 (6.2) 11.5 (6–15) 15 (9–18) 12 (8–18) <0.0001
Number domiciliary drugs � 8.8 (4) 9.2 (3.7) 11 (6.3) 8 (6–12) 9 (7–12) 9 (6–12) 0.7
Hospital stay (days) � 10.7 (6.8) 11.5 (10.4) 11.1 (8.8) 9 (6–14) 8 (6–13) 9 (6–13) 0.7
Number of hospitalizations �# 2.6 (2.7) 2.1 (2.4) 2.3 (2.5) 2 (0–4) 1 (0–3) 2 (0–4) 0.02
Qualitative variables number (%) number (%) number (%)
Coexistence
Alone 58 (14.1%) 57 (13.3%) 115 (13.7%) 0.01
Family 286 (69.4%) 269 (62.9%) 555 (66.1%)
Profesioneal caregiver or nursing
home
63 (15.3%) 101 (23.6%) 164 (19.5%)
Others 5 (1.2%) 1 (0.2%) 6 (0.7%)
Delirium 190 (46%) 269 (63%) 464 (55%) <0.0001
Dysphagia 190 (45%) 241 (58%) 430 (51%) 0.002
Comorbity_scale
Hearth failure 224 (54%) 266 (62.1%) 490 (58.1%) 0.01
Ischemic heart disease 121 (29.2%) 77 (18%) 198 (23.5) <0.0001
Autoinmune 31 (7.5%) 52 (12.1%) 83 (9.8%) 0.01
Chronic Kidney Dis. 195 (47%) 178 (41.6%) 373 (44.2%) 0.06
Chronic Respiratory Dis. 227 (54.7%) 181 (42.3%) 408 (48.4%) <0.0001
Inflamatory bowel Dis. 9 (2.2%) 14 (3.3%) 23 (2.7%) 0.2
Chronic Liver Dis. 29 (7%) 20 (4.7%) 49 (5.8%) 0.1
Cerebrovascular 99 (23.9%) 93 (21.7%) 192 (22.8%) 0.3
Motor Neurological Dis. 49 (11.8%) 51 (11.9%) 100 (11.9%) 0.5
Dementia 141 (34%) 198 (46.3%) 339 (40.2%) <0.0001
Peripheral artery Dis. 78 (18.8%) 30 (7%) 108 (12.8%) <0.0001
Diabetes 114 (27.5%) 114 (26.6%) 228 (27%) 0.04
Chronic anemia 63 (15.2%) 77 (18%) 140 (16.6%) 0.2
Neoplasm 70 (16.9%) 32 (7.5%) 102 (12.1%) 0.0001
Chronic osteoarticular Dis. 41 (9.9%) 128 (29.9%) 169 (20%) 0.0001
Total comorbidity scale� 3.6 (1.5) 3.5 (1.4) 3.5 (1.5) 3.6 (2–5) 3.5 (2–4) 3.5 (2–5) 0.7
�Non-normal distribution (Kolmogorov-Smirnoff. Analyses performed with Mann-Whitney U test.
# Number of hospitalizations in the previous year.
https://doi.org/10.1371/journal.pone.0227252.t001
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[15 (IQR:12–18) vs. 12 (IQR:7–16); p<0.0001], and greater cognitive impairment (Pfeiffer 6
(IQR: 2–9) vs. 2 (IQR:0–8); p<0.0001]. No differences were found with respect to the number
of multimorbidity criteria, hospitalizations during the previous year, and number of chronic
domiciliary drugs, between those deceased during admission and patients discharged alive. In
the gender analysis, females who died during index hospitalization were older than males [87.3
(IQR:83–92) vs. 84.2 (IQR:80–89); p = 0.006], without differences in Charlson, Barthel, or
PROFUND indexes, Pfeiffer test, or number of multimorbidity criteria. Only respiratory pat-
tern in males was significantly associated with in-hospital mortality (p = 0.004). For the 122
patients deceased during the index stay, treatment ceiling was agreed upon with patients or
caregivers in 110 (92.4%), and symptomatic treatment was initiated.
Readmissions
Of the 721 patients discharged alive, eighty-six patients (11.9%)—45 (12.8%) males and 41
(11.1%) females—were readmitted within 1 month of discharge. To avoid immortal time bias
we excluded patients who died after hospital discharge without readmission during the month
after discharge. In this analysis the percentage of readmission was slightly higher (14.9% males
and 12.9% females), without significant gender differences. Patients readmitted or dying dur-
ing the month after discharge were older [85 (IQR: 79–89) vs. 83 (IQR: 78–88) years; p = 0.03]
and had a higher number of hospital admissions in the previous year [2 (IQR:1–4) vs. 1 (IQR:
0–3); p = 0.02], as well as having more comorbidity [Charlson index: 5 (IQR:3–7) vs. 4
(IQR:3–6);p = 0.01], functional dependence [Barthel index: 40 (IQR: 10–75) vs. 55 (IQR: 25–
85);p<0.0001], and cognitive impairment [Pfeiffer test: 4 (IQR:1–9) vs. 2 (IQR: 0–8);
p = 0.007], as well as higher scores on the PROFUND index [14 (IQR:9–18) vs. 11 (IQR: 6–15);
p<0.0001). The leading causes of readmission were a new exacerbation of chronic disease in
14 cases (16.3%), infection related with the previous admission in 18 (20.9%), falls with trau-
matism in 7 (8.1%), dysphagia with aspiration in 28 (32.6%), and other causes in 19 (22.1%).
Readmissions for a new exacerbation were more frequent in women, while dysphagia with
aspiration was more frequent in men. “Fig 3”
During the year after discharge, 237 (67.3%) men and 248 (67.8%) women were readmitted
(p = 0.4). The number of 1-year readmissions was similar for males and females: 1(IQR:0–3).
“Table 3”.
1-year mortality
One-year follow-up was available for 714 (99%) patients. Of these, 330 (46.2%) died; 152
(43.3%%) were men and 178 (49%) women (p = 0.1). “Fig 4”. The median follow-up for
deceased patients was 76 (IQR: 22–178) days. Predictors of 1-year mortality are detailed in
Table 3. “Table 3”. In the multivariate Cox regression analysis age, Charlson index, Barthel,
Table 2. Gender patterns of multimorbidity.
men women total p
Metabolic diseases 363 (87.5%) 379 (88.6%) 742 (88%) 0.3
Cardiovascular diseases 304 (73.3%) 319 (74.5%) 623 (73.9%) 0.3
Neurological diseases 257 (61.9%) 318 (74.3%) 575 (68.2%) <0.0001
Respiratory diseases 228 (54.9%) 182 (42.5%) 410 (48.6%) <0.0001
Osteoarticular diseases 78 (18.8%) 199 (46.5%) 277 (32.9%) <0.0001
Neoplasm 70 (16.9%) 32 (7.5%) 102 (12.1%) <0.0001
Miscellanea 209 (50.4%) 225 (52.6%) 434 (51.5%) 0.3
https://doi.org/10.1371/journal.pone.0227252.t002
Gender and multimorbidity
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PROFUND, and previous admissions were predictors of 1-year mortality, while gender and
the Pfeiffer test did not reach statistical significance in this model. “Table 4”.
In the analysis of predictor models, performed with the cumulative/dynamic ROC curves,
the AUC for 1-year mortality was 0.63, 0.67, and 0.68 for Charlson, Barthel, and PROFUND,
respectively. “S2 Fig”.
Regarding gender, PROFUND and Charlson index were better predictors of mortality in
men than in women (AUC 0.74 for men vs. 0.62 for women in PROFUND index: p<0.001,
Fig 2. The diameter of the spheres represents the prevalence in pattern percentage, while union lines express the
frequency of the relationship. Violet lines>60%, Blue lines 51–60%, Red lines 41–50%, Green lines 31–40%%,
Orange lines 21–30, Brown lines 11–20%, Black lines<11%. � The association between patterns is statistically
significantly higher in men than in women. & The association between patterns is statistically significantly higher in
women than in men.
https://doi.org/10.1371/journal.pone.0227252.g002
Gender and multimorbidity
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and 0.70 vs. 0.57 on the Charlson index for men and women: p<0.001). No differences were
observed in the Barthel index according to gender. “Fig 5” Of the 167 patients with the highest
quartiles in the PROFUND index (> 16 points), 63 (37.7%) were alive at the end of follow-up.
Similarly, of the 148 patients with the worst scores on the Charlson index, 60 (40.5%) were
alive at one year.
Discussion
Our study demonstrates the presence of differences in gender patterns in multimorbidity
patients hospitalized for decompensation of chronic diseases. Women were older, with greater
functional dependence measured with the Barthel index and worse scores in cognitive evalua-
tion. Conversely, males had a higher comorbidity load according to the Charlson index. In the
multimorbidity scale, dementia, heart failure, and osteoarticular diseases predominated in
Fig 3. Main cause and gender differences in 30-day readmissions.
https://doi.org/10.1371/journal.pone.0227252.g003
Table 3. Univariate predictors of 1-year mortality.
Quantitative variables Death (median;IQR) Alive (median;IQR) Hazard ratio 95% C.I. p
Age 85 (80–89) 82 (75–87) 1.04 1.02–1.05 <0.0001
Barthel 40 (10–65) 65 (40–90) 0.98 0.98–0.99 <0.0001
Pfeiffer 5 (0–9) 1 (0–6) 1.1 1.07–1.14 <0.0001
Charlson age-adjusted 9 (7–11) 8 (6–10) 1.15 1.11–1.2 <0.0001
Charlson 5 (3–7) 4 (3–6) 1.12 1.07–1.17 <0.0001
Number of hospitalizations in the previous year 2 (1–4) 1 (0–3) 1.06 1.02–1.09 0.003
Number of multimorbidity criteria 4 (3–5) 3 (2–4) 1.11 1.03–1.19 0.005
Qualitative variables
Gender (men) 151 (46.6%) 173 (53.4%) 0.85 0.69–1.06 0.2
Gender (women) 198 (52.1%) 182 (47.9%)
Delirium 150 (60.5%) 115 (36.4%) 2.25 1.73–2.87 <0.0001
Dysphagia 109 (53.4%) 70 (28%) 2.34 1.78–3.08 <0.0001
https://doi.org/10.1371/journal.pone.0227252.t003
Gender and multimorbidity
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women, while in men ischemic heart disease, chronic respiratory diseases, and neoplasm were
more prevalent. In the analysis of grouped patterns, neurological and osteoarticular diseases
were more frequent in females, while respiratory diseases and cancer predominated in males.
To our knowledge, there are no previous studies that have explicitly explored gender pat-
terns of multimorbidity in hospitalized older patients and their prognosis implications. We
did not find differences by gender in terms of in-patient mortality or survival during the fol-
low-up. This is in line with two Spanish studies performed in a population with similar charac-
teristics to ours, although some previous reports have shown higher post-hospital mortality in
males [10, 23,24,25].
In-patient mortality in our population (14.9%) was higher than that previously reported in
other studies. According to the data from the Spanish National Statistics Institute in 2017,
Fig 4. Kaplan-Meier survival curves and gender.
https://doi.org/10.1371/journal.pone.0227252.g004
Table 4. Multivariate 1-year mortality analysis.
H.R. 95% C.I. p
Gender 1.1 0.83–1.44 0.6
Age 1.02 1.01–1.04 0.03
Charlson index� 1.03 1.02–1.05 <0.006
Barthel index 0.99 0.98–0.99 0.02
PROFUND index 1.06 1.03–1.1 <0.0001
Number hospitalizations in the previous year 1.07 1.01–1.12 0.01
Pfeiffer 0.97 0.92–1.04 0.4
�Charlson index without age adjustment Please upload each supporting information element within separate files.
https://doi.org/10.1371/journal.pone.0227252.t004
Gender and multimorbidity
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internal medicine services in Spain issued a total of 905,659 hospital discharges, with a mortal-
ity rate of 9.24% [26]. However, the mean age of our population was nine years older, and the
Charlson comorbidity index almost three times higher [27]. Our data on hospital mortality are
similar to what was observed in studies performed with similar inclusion criteria, and we
believe that the differences in mortality rates may simply reflect a sicker patient population
[23,24,25]. Previous studies have shown that 70–80% of patients that die in hospital are frail,
older patients with multiple comorbidities who were admitted through emergency rooms [28].
With many of these patients the main goal is not to prolong survival, but to reach agree-
ment with the patient and caregivers on an individualized care plan and the careful treatment
of distressful symptoms (dyspnea, confusion, pain, etc.) [29,30]. Furthermore, predicting the
short-term prognosis of an individual patient is often difficult. A useful and well-valued
approach for patients and physicians is to establish a therapeutic ceiling (for example, not to
initiate cardiopulmonary resuscitation or to limit ventilator support to non-invasive ventila-
tion) [31]. In more than ninety percent of patients dying during the index stay, the ceiling of
treatment was previously agreed upon with the patients, or, if this was not possible due to the
patient’s condition, with their caregivers (usually the spouse or the children), and symptomatic
or palliative treatment was started.
The observed percentage of readmissions in the month after discharge may be considered
low. More importantly, the cause of readmission was in many cases related to secondary com-
plications from the previous hospitalization. Although readmission is considered a criterion of
quality of care, the Medicare data show that less than 40% of patients discharged with a diag-
nosis of heart failure, pneumonia, or chronic obstructive pulmonary disease are readmitted in
the subsequent 30 days for the same cause, and fewer than one in four readmissions were
deemed avoidable [32]. In the rest of the cases, readmissions were related to a vulnerable
period after admission, called the post-hospital syndrome [33]. During this period, patients are
more vulnerable to infections, falls, and reversible dysphagia [33,34]. Obviously, this vulnera-
ble period is more relevant in previously frail elderly patients [25,35]. Classic studies have
Fig 5. Dynamic cumulative ROC curves and1-year mortality for PROFUND, Charlson index, and Barthel scale. Black = male. Gray = female.
https://doi.org/10.1371/journal.pone.0227252.g005
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shown that from 25% to 50% of elderly patients hospitalized for medical illness have a loss of
independence in daily life activities, and that physical activity during hospital stays is severely
reduced [36,37].
The figure for 1-year mortality observed in our study (46%) is in accordance with results
published in other similar Spanish cohorts, where they ranged between 40% and 50%. In these
studies as well, no differences were found in mortality by gender [23,24,38,39,40]. Addition-
ally, our study confirms the reliability of the PROFUND and Charlson indexes in the predic-
tion of 1-year mortality. The AUC observed for the PROFUND index (0.68) is nearly identical
to the figures observed in these previous studies (0.7).
A relevant observation from our study, and one not previously explored, is that the predic-
tive capacity of the Charlson and PROFUND indexes is clearly superior in males. That is, mor-
tality is less predictable in women. In any case, although the performance of Charlson and
PROFUND in our study may be considered good, we believe that no single predictive index
should be used as an exclusive criterion to predict mortality in an individual multimorbid
patient. For example, in the patients with worse scores on the PROFUND and Charlson index,
40% were alive at the end of follow-up; this percentage increased to 50% for the Charlson
index in women. These data highlight the need for prior advanced decisions agreed upon with
the patient and their caregivers. The unpredictability of the date of death should not involve
subjecting the patient to unwanted aggressive care.
Our study has several limitations. First, it was conducted in a single center, with a specialized
unit focused on the care of these patients, so perhaps the results cannot be extrapolated to other
populations. However, the number of included patients was considerable, and their characteris-
tics very similar to those observed in multicenter studies performed in the same geographical
area. [17,23,24,38,39,40] Second, our study focuses on hospitalized elderly multimorbidity
patients requiring complex health care, and their definition is not universally accepted. Cur-
rently, multimorbidity is defined as the presence of two or more chronic diseases in the same
subject or the combination of one chronic illness with at least one other disease (acute or
chronic) or bio-psychosocial factor [41]. This definition is too broad and fails to capture the
complexity of some populations. For example, with this definition practically all community
persons older than 85 years of age can be classified as multimorbid—since chronic diseases are
closely linked to aging—and therefore the utility of this definition with this population is ques-
tionable [42]. More recently, some authors and health organizations have used different terms
for patients such as complex chronic care or great health care needs. These patients are generally
the frail elderly with multimorbidity, and we believe that this classification better describes our
population [43]. Finally, other useful predictors of mortality in elderly multimorbid patients,
such as the history of previous syncope, were not analyzed in our study [44].
In conclusion, our data confirm the differences in gender patterns of multimorbidity and
the male-female health-survival paradox. Women were older, with greater functional depen-
dence and greater prevalence of dementia and heart failure. Conversely, males had a greater
load of global comorbidity measured with the Charlson index, and a greater predominance of
ischemic heart disease, chronic respiratory diseases, and neoplasm.
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